Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover Study.
- DOI
- 10.1007/s12325-026-03703-3
- Published
- 2026 Jul 24
- Container
- Advances in therapy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-026-03703-3,
title = {Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover Study.},
author = {Elliot ER and Boles J and Fox D and Nelson KL and Dupont-Benjamin L and Vutikullird A and Mottola A and Fletcher K and Wang K and Somvanshi S and Grove R and Strano K and Pilgrim N and Borsi R and Budnik P and van Wyk J and Garges HP and Brown K},
year = {2026},
journal = {Advances in therapy},
doi = {10.1007/s12325-026-03703-3},
url = {https://doi.org/10.1007/s12325-026-03703-3}
}RIS
TY - JOUR TI - Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover Study. AU - Elliot ER AU - Boles J AU - Fox D AU - Nelson KL AU - Dupont-Benjamin L AU - Vutikullird A AU - Mottola A AU - Fletcher K AU - Wang K AU - Somvanshi S AU - Grove R AU - Strano K AU - Pilgrim N AU - Borsi R AU - Budnik P AU - van Wyk J AU - Garges HP AU - Brown K PY - 2026 JO - Advances in therapy DO - 10.1007/s12325-026-03703-3 UR - https://doi.org/10.1007/s12325-026-03703-3 ER -
APA
ER, E., J, B., D, F., KL, N., L, D., A, V., A, M., K, F., K, W., S, S., R, G., K, S., N, P., R, B., P, B., J, V. W., HP, G., & K, B. (2026). Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover Study.. Advances in therapy. https://doi.org/10.1007/s12325-026-03703-3
Source records
- pubmed · retrieved 2026-09-26T02:39:21.498Z
- europe-pmc · retrieved 2026-09-26T02:39:21.502Z